Aims and objectives
The objective of this study was to analyze the accuracy of abdominal ultrasonography in the assessment of mucosal healing in patients with Crohn's disease receiving immunomodulators and/or biological treatment, with ileocolonoscopy as the reference standard.
Methods and materials
We made a review of all patients with Crohn disease who had begun treatment with immunomodulators and/or biological drugs in our Hospital, between March 2008 and December 2011. Information has been prospectively collected.
Inclusion criteria:
• Older than 17 years of age. • Indication to begin immunomodulators and/or biological treatment.
• Maintenance of treatment response for at least one year without receiving any other treatment during that time.
Initial ileocolonoscopy and abdominal ultrasound was two weeks previously to the start of immunomodulators or biological therapy (interval between techniques maximum 7days), and were repeated after a minimum of 1 year from the start of treatment.
Endoscopic protocol
The endoscopic findings were evaluated by calculating the Crohn's Disease Endoscopic Index of Severity (CDEIS): evaluates the severity of endoscopic lesions, obtaining a score based on the division of the bowel explored by ileocolonoscopy into segments (rectum, sigmoid and left colon, transverse colon, right colon and ileum) and the presence of four findings in each segment (deep ulcers, superficial ulcers, surface of the segment affected by disease, surface of the segment affected by ulcers) and stenosis (ulcerated or nonulcerated). The CDEIS score covers from 0 to 44 points (higher score indicates a greater severity).
The findings were assessed both separately for each segment and globally. Mucosal healing was considered when ulcers had disappeared and the induced endoscopic remission when the CDEIS < 6 points.
Ultrasound protocol
US examinations were performed by using a Aplio 80; Toshiba, Tokyo, Japan, initially employing a 3-6 MHz convex-array transducer and then a 6-10 MHz probe for a detailed examination, initially in gray-scale.
The intensity of the color Doppler flow was subjectively graded as absent (grade 0), barely-visible vascularity (grade 1), moderate (grade 2) and marked (grade 3).
CEUS was performed with a 3-4 MHz convex probe in wideband harmonic contrast mode (pulse inversion -Toshiba Aplio) at low MI (MI b 0.10). The second generation echosignal enhancer SonoVue® was injected as a bolus in units of 1.2 mL, followed immediately by injection of 10 mL of normal saline solution (0.9% NaCl).
To assess the vascularization of the involved bowel loop, the contrast uptake was measured over a period of 40 s.
Quantitative analysis of the enhancement after contrast agent injection was calculated by the percentage of increase in wall brightness by using the following formula: [(brightness post-contrast # brightness pre-contrast) × 100] / brightness pre-contrast.
The ultrasound examination assessed Fig. 1 on page 5:
1.
Thickness of the wall of the affected segment (abnormal >3 mm). 2.
Vascularization of the wall bycolor Doppler US. 3.
Percentage of increase of enhancement in wall brightness after contrast injection.
Ultrasound remission was considered :
Intestinal wall thickness was ≤3 mm, 2.
Color Doppler flow in the intestinal wall, grade 0 or 1 3.
Percentage of parietal enhancement increase less than 46%.
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Results
Endoscopic Findings: Table 1 on page 8 Thirty patients and 168 segments were evaluated.
Pre-treatment ileocolonscopies were completed in 18 patients (60%) and in 12 (40%) were incomplete (in 8 patients persented of stenosis or severe lesions in 4 patients).
All patients had at least one segment with ulcers and 100% of the patients had a CDEIS > 6 points.
After treatment the number of complete endoscopies increased to 23 (76.7%) patients; and in 7 (23.3%) patients were incompleted (persistent stenosis in 5 and appearance of a new stenosis in 1 patient, and other was no complete for technical reasons).
In the post-treatment ileocolonoscopy, 18 (60%) patients showed endoscopic remission.
Ultrasound findings: Table 2 on page 8
Thirty patients and 178 segments were evaluated.
All patients presented at least one abnormal segment on the initial AUS. All ultrasound variables evaluated (mural thickness, color Doppler grade, percentage of increase of parietal enhancement) showed statistically significant improvement after treatment.
Segmental assessment
The comparative analysis by segments between endoscopy and sonography before the start of treatment showed a good correlation, especially in the more proximal intestinal segments, with # index scores of 0.47, 0.85, 0.82, 0.80, 0.9 and 1.0 for the rectum, sigmoid colon, descending colon, transverse colon, ascending colon-cecum and ileum, respectively.
59 segments with ulcers were evaluated with both techniques.
Healing of endoscopic lesions was observed in 42 of these segments, 37 of which also exhibited normalized sonographic findings, showing a good correlation between both techniques (# index: 0.76; p < 0.001).
Ultrasound presents an accuracy of 89.8% (95% CI: 79.5-95.3)in predicting the presence of mucosal healing on endoscopy.
The sonographic variable with the best correlation with endoscopy in the assessment of mucosal healing was the color Doppler grade of the intestinal wall (# = 0.82, p < 0.001); intestinal wall thickness and parietal contrast enhancement showed a correlation with endoscopic mucosal healing of 0.76 and 0.67 (p < 0.001), respectively.
Multivariate analysis found intestinal wall thickness # 3 mm like the variable which best helped predict endoscopic healing (92.5%).
Overall assessment
Of the 18 (60%) patients showing endoscopic remission, 15 (83.3%) patients exhibited normalized sonographic findings.
The correlation between endoscopic remission and a normal ultrasound was good (# = 0.73, p < 0.001).
Ultrasound presents an accuracy of 86.4% (95% CI: 75.5-93.0) in predicting endoscopic remission.
The ultrasound variable which showed the best correlation with endoscopy for predicting endoscopic remission was intestinal wall thickness # 3 mm (# = 0.86, p < 0.001); intestinal wall color Doppler and parietal contrast enhancement showed a correlation with endoscopic remission of 0.85 and 0.76 (p < 0.001), respectively. After multivariate analysis the variable with the best prognostic value was intestinal wall thickness # 3 mm (95.5%).
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Conclusion
Abdominal ultrasound presents a high accuracy to predict endoscopic remission (89.8% in segmental analysis and 84.6% in global analysis).
The thickness of the wall # 3mm was the variable with more correlation with endoscopic mucosal healing (in both analysis, by segments or global intestine).
Abdominal ultrasonography is a useful, non invasive and reliable technique for the assessment of the endoscopic response to treatment with immunomodulators and/or biological drugs in Crohn's disease.
